Perceive Biotherapeutics CEO Angela Macfarlane (L) and president Anne Rubin
January 6, 2023 06:25 AM ESTUpdated 09:48 AM
Financing

Up­dat­ed: Stealth biotech Per­ceive rais­es $78M from J&J and Deer­field, says lit­tle about eye dis­ease pro­grams

Lei Lei Wu

News Reporter

Eye dis­ease biotech Per­ceive Bio­ther­a­peu­tics an­nounced Thurs­day that it has raised $78 mil­lion in a Se­ries B, though it says it is re­main­ing in stealth …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Lasker Award goes to three sci­en­tists who pi­o­neered re­search be­hind GLP-1 drugs

FDA in­spec­tors dis­cov­er trucks car­ry­ing torn-up records leav­ing In­di­an gener­ics fac­to­ry

Ali­gos’ tri­al for oral MASH treat­ment suc­ceeds, but place­bo group shows odd trend

Ex­clu­sive: Flag­ship-backed Va­lo Health los­es in­ter­im CEO ahead of key Phase 2 read­out

Stem cell start­up spun out of George Church’s lab rais­es $75M

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times